210 related articles for article (PubMed ID: 29593542)
1. Apigenin and Luteolin Attenuate the Breaching of MDA-MB231 Breast Cancer Spheroids Through the Lymph Endothelial Barrier
Hong J; Fristiohady A; Nguyen CH; Milovanovic D; Huttary N; Krieger S; Hong J; Geleff S; Birner P; Jäger W; Özmen A; Krenn L; Krupitza G
Front Pharmacol; 2018; 9():220. PubMed ID: 29593542
[TBL] [Abstract][Full Text] [Related]
2. NF-κB contributes to MMP1 expression in breast cancer spheroids causing paracrine PAR1 activation and disintegrations in the lymph endothelial barrier in vitro.
Nguyen CH; Senfter D; Basilio J; Holzner S; Stadler S; Krieger S; Huttary N; Milovanovic D; Viola K; Simonitsch-Klupp I; Jäger W; de Martin R; Krupitza G
Oncotarget; 2015 Nov; 6(36):39262-75. PubMed ID: 26513020
[TBL] [Abstract][Full Text] [Related]
3. Fenofibrate inhibits tumour intravasation by several independent mechanisms in a 3-dimensional co-culture model.
Nguyen CH; Huttary N; Atanasov AG; Chatuphonprasert W; Brenner S; Fristiohady A; Hong J; Stadler S; Holzner S; Milovanovic D; Dirsch VM; Kopp B; Saiko P; Krenn L; Jäger W; Krupitza G
Int J Oncol; 2017 May; 50(5):1879-1888. PubMed ID: 28393180
[TBL] [Abstract][Full Text] [Related]
4. AHR/CYP1A1 interplay triggers lymphatic barrier breaching in breast cancer spheroids by inducing 12(S)-HETE synthesis.
Nguyen CH; Brenner S; Huttary N; Atanasov AG; Dirsch VM; Chatuphonprasert W; Holzner S; Stadler S; Riha J; Krieger S; de Martin R; Bago-Horvath Z; Krupitza G; Jäger W
Hum Mol Genet; 2016 Nov; 25(22):5006-5016. PubMed ID: 28171546
[TBL] [Abstract][Full Text] [Related]
5. In vitro characterisation of the anti-intravasative properties of the marine product heteronemin.
Kopf S; Viola K; Atanasov AG; Jarukamjorn K; Rarova L; Kretschy N; Teichmann M; Vonach C; Saiko P; Giessrigl B; Huttary N; Raab I; Krieger S; Schumacher M; Diederich M; Strnad M; de Martin R; Szekeres T; Jäger W; Dirsch VM; Mikulits W; Grusch M; Dolznig H; Krupitza G
Arch Toxicol; 2013 Oct; 87(10):1851-61. PubMed ID: 23543012
[TBL] [Abstract][Full Text] [Related]
6. Intravasation of SW620 colon cancer cell spheroids through the blood endothelial barrier is inhibited by clinical drugs and flavonoids in vitro.
Holzner S; Brenner S; Atanasov AG; Senfter D; Stadler S; Nguyen CH; Fristiohady A; Milovanovic D; Huttary N; Krieger S; Bago-Horvath Z; de Wever O; Tentes I; Özmen A; Jäger W; Dolznig H; Dirsch VM; Mader RM; Krenn L; Krupitza G
Food Chem Toxicol; 2018 Jan; 111():114-124. PubMed ID: 29129665
[TBL] [Abstract][Full Text] [Related]
7. 12(S)-HETE increases intracellular Ca(2+) in lymph-endothelial cells disrupting their barrier function in vitro; stabilization by clinical drugs impairing calcium supply.
Nguyen CH; Brenner S; Huttary N; Li Y; Atanasov AG; Dirsch VM; Holzner S; Stadler S; Riha J; Krieger S; Milovanovic D; Fristiohardy A; Simonitsch-Klupp I; Dolznig H; Saiko P; Szekeres T; Giessrigl B; Jäger W; Krupitza G
Cancer Lett; 2016 Sep; 380(1):174-83. PubMed ID: 27390016
[TBL] [Abstract][Full Text] [Related]
8. Xanthohumol attenuates tumour cell-mediated breaching of the lymphendothelial barrier and prevents intravasation and metastasis.
Viola K; Kopf S; Rarova L; Jarukamjorn K; Kretschy N; Teichmann M; Vonach C; Atanasov AG; Giessrigl B; Huttary N; Raab I; Krieger S; Strnad M; de Martin R; Saiko P; Szekeres T; Knasmüller S; Dirsch VM; Jäger W; Grusch M; Dolznig H; Mikulits W; Krupitza G
Arch Toxicol; 2013 Jul; 87(7):1301-12. PubMed ID: 23503627
[TBL] [Abstract][Full Text] [Related]
9. 12(S)-HETE induces lymph endothelial cell retraction in vitro by upregulation of SOX18.
Fristiohady A; Milovanovic D; Krieger S; Huttary N; Nguyen CH; Basilio J; Jäger W; De Martin R; Krupitza G
Int J Oncol; 2018 Jul; 53(1):307-316. PubMed ID: 29749465
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of tumour spheroid-induced prometastatic intravasation gates in the lymph endothelial cell barrier by carbamazepine: drug testing in a 3D model.
Teichmann M; Kretschy N; Kopf S; Jarukamjorn K; Atanasov AG; Viola K; Giessrigl B; Saiko P; Szekeres T; Mikulits W; Dirsch VM; Huttary N; Krieger S; Jäger W; Grusch M; Dolznig H; Krupitza G
Arch Toxicol; 2014 Mar; 88(3):691-9. PubMed ID: 24352538
[TBL] [Abstract][Full Text] [Related]
11. NF-κB mediates the 12(S)-HETE-induced endothelial to mesenchymal transition of lymphendothelial cells during the intravasation of breast carcinoma cells.
Vonach C; Viola K; Giessrigl B; Huttary N; Raab I; Kalt R; Krieger S; Vo TP; Madlener S; Bauer S; Marian B; Hämmerle M; Kretschy N; Teichmann M; Hantusch B; Stary S; Unger C; Seelinger M; Eger A; Mader R; Jäger W; Schmidt W; Grusch M; Dolznig H; Mikulits W; Krupitza G
Br J Cancer; 2011 Jul; 105(2):263-71. PubMed ID: 21629247
[TBL] [Abstract][Full Text] [Related]
12. Feed‑back loops integrating RELA, SOX18 and FAK mediate the break‑down of the lymph‑endothelial barrier that is triggered by 12(S)‑HETE.
Engleitner S; Milovanovic D; Kirisits K; Brenner S; Hong J; Ropek N; Huttary N; Rehak J; Nguyen CH; Bago-Horvath Z; Knasmüller S; De Martin R; Jäger W; Krupitza G
Int J Oncol; 2020 Apr; 56(4):1034-1044. PubMed ID: 32319559
[TBL] [Abstract][Full Text] [Related]
13. Flavonoids Distinctly Stabilize Lymph Endothelial- or Blood Endothelial Disintegration Induced by Colon Cancer Spheroids SW620.
Berenda J; Smöch C; Stadlbauer C; Mittermair E; Taxauer K; Huttary N; Krupitza G; Krenn L
Molecules; 2020 Apr; 25(9):. PubMed ID: 32365473
[TBL] [Abstract][Full Text] [Related]
14. In vitro inhibition of breast cancer spheroid-induced lymphendothelial defects resembling intravasation into the lymphatic vasculature by acetohexamide, isoxsuprine, nifedipin and proadifen.
Kretschy N; Teichmann M; Kopf S; Atanasov AG; Saiko P; Vonach C; Viola K; Giessrigl B; Huttary N; Raab I; Krieger S; Jäger W; Szekeres T; Nijman SM; Mikulits W; Dirsch VM; Dolznig H; Grusch M; Krupitza G
Br J Cancer; 2013 Feb; 108(3):570-8. PubMed ID: 23299527
[TBL] [Abstract][Full Text] [Related]
15. Effects of the vegetable polyphenols epigallocatechin-3-gallate, luteolin, apigenin, myricetin, quercetin, and cyanidin in primary cultures of human retinal pigment epithelial cells.
Chen R; Hollborn M; Grosche A; Reichenbach A; Wiedemann P; Bringmann A; Kohen L
Mol Vis; 2014; 20():242-58. PubMed ID: 24623967
[TBL] [Abstract][Full Text] [Related]
16. Bay11-7082 inhibits the disintegration of the lymphendothelial barrier triggered by MCF-7 breast cancer spheroids; the role of ICAM-1 and adhesion.
Viola K; Kopf S; Huttary N; Vonach C; Kretschy N; Teichmann M; Giessrigl B; Raab I; Stary S; Krieger S; Keller T; Bauer S; Hantusch B; Szekeres T; de Martin R; Jäger W; Mikulits W; Dolznig H; Krupitza G; Grusch M
Br J Cancer; 2013 Feb; 108(3):564-9. PubMed ID: 23093227
[TBL] [Abstract][Full Text] [Related]
17. Luteolin and its derivative apigenin suppress the inducible PD-L1 expression to improve anti-tumor immunity in KRAS-mutant lung cancer.
Jiang ZB; Wang WJ; Xu C; Xie YJ; Wang XR; Zhang YZ; Huang JM; Huang M; Xie C; Liu P; Fan XX; Ma YP; Yan PY; Liu L; Yao XJ; Wu QB; Lai-Han Leung E
Cancer Lett; 2021 Sep; 515():36-48. PubMed ID: 34052328
[TBL] [Abstract][Full Text] [Related]
18. Transcriptomic and Functional Evidence That miRNA193a-3p Inhibits Lymphatic Endothelial Cell (LEC) and LEC + MCF-7 Spheroid Growth Directly and by Altering MCF-7 Secretome.
Azzarito G; Henry M; Rotshteyn T; Leeners B; Dubey RK
Cells; 2023 Jan; 12(3):. PubMed ID: 36766731
[TBL] [Abstract][Full Text] [Related]
19. Cytochrome P450 CYP1 metabolism of hydroxylated flavones and flavonols: Selective bioactivation of luteolin in breast cancer cells.
Wilsher NE; Arroo RR; Matsoukas MT; Tsatsakis AM; Spandidos DA; Androutsopoulos VP
Food Chem Toxicol; 2017 Dec; 110():383-394. PubMed ID: 29097115
[TBL] [Abstract][Full Text] [Related]
20. Anti-inflammatory activity of structurally related flavonoids, Apigenin, Luteolin and Fisetin.
Funakoshi-Tago M; Nakamura K; Tago K; Mashino T; Kasahara T
Int Immunopharmacol; 2011 Sep; 11(9):1150-9. PubMed ID: 21443976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
